Ian Taylor - 01 Mar 2023 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Scientific Officer
Signature: /s/ Matthew Batters, as attorney-in-fact for Ian Taylor
Issuer symbol: ARVN
Transactions as of: 01 Mar 2023
Net transactions value: -$31,036
Form type: 4
Filing time: 03 Mar 2023, 20:51:13 UTC
Previous filing: 24 Feb 2023
Next filing: 08 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Options Exercise		+2,685	+2.7%		102,772	01 Mar 2023	Direct	F1
transaction	ARVN	Common Stock	Sale	$31,036	-1,051	-1%	$29.53	101,721	01 Mar 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARVN	Restricted Stock Units	Options Exercise	$0	-2,685	-100%	$0.000000^*	0	01 Mar 2023	Common Stock	2,685		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2	This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3	The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at a price of $29.53.
F4	On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.